Clinical trials

Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.

201 studies match

clinicaltrialsPublishedShowing 51–100 of 201 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03600883	A Phase 1/2, Study Evaluating the Safety, Tolerability, PK, and Efficacy of Sotorasib (AMG 510) in Subjects With Solid Tumors With a Specific KRAS Mutation (CodeBreaK 100)	completed	Phase 1 / Phase 2	713	AmgenINDUSTRY	16	Jun 30, 2026	clinicaltrials
NCT05325866	A Study Evaluating Bemarituzumab in Solid Tumors With Fibroblast Growth Factor Receptor 2b (FGFR2b) Overexpression(FORTITUDE-301)	terminated	Phase 1 / Phase 2	260	AmgenINDUSTRY	26	Jun 22, 2026